Investor
Madrona Venture Group, LLC
CIK 0001887785 · filed 2026-02-13 · SEC filing
13F book
$22.1K
Positions
3
Largest name
53.2%
Nautilus Biotechnology, Inc. · NAUT
Est. mark
—
Need a prior quarter to estimate
| Name | Ticker | Shares | Value | Weight | Est. mark | Change |
|---|---|---|---|---|---|---|
| Nautilus Biotechnology, Inc. | NAUT | 6.02M | $11.7K | 53.2% | — | Held |
| UiPath, Inc. | PATH | 607.7K | $9.96K | 45.2% | — | Held |
| Ginkgo Bioworks Holdings Inc | — | 42.4K | $353 | 1.6% | — | Held |
Positions as of Q4 2025. 13F filings arrive up to 45 days after quarter-end and omit shorts. Values are quarter-end marks, as filed. Estimated mark is the price effect on shares still held — not realized P&L or investment advice.